Özlem Yersal

1.4k total citations · 1 hit paper
15 papers, 994 citations indexed

About

Özlem Yersal is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Özlem Yersal has authored 15 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Özlem Yersal's work include Inflammatory Biomarkers in Disease Prognosis (6 papers), MRI in cancer diagnosis (2 papers) and Brain Metastases and Treatment (2 papers). Özlem Yersal is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (6 papers), MRI in cancer diagnosis (2 papers) and Brain Metastases and Treatment (2 papers). Özlem Yersal collaborates with scholars based in Türkiye. Özlem Yersal's co-authors include Sabri Barutça, Esin Oktay, Nezih Meydan, Hatice Ertabaklar, Erdoğan Malatyalı, Sema Ertuğ, Sevil Kılçıksız, Ufuk Eryılmaz, Gamze Göksel and Özgür Tanrıverdi and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Hematology and Future Oncology.

In The Last Decade

Özlem Yersal

15 papers receiving 981 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biological subtypes of breast cancer: Prognostic and therapeutic implications

2014 784 citations Özlem Yersal World Journal of Clinical Oncology profile →

Peers

Özlem Yersal

MB

ONCOL

CR

PRM

GENET

Shane O’Grady Ireland

Yilun Chen Sweden

Jizu Zhi United States

Emmanuel Blot France

Antje Lebrecht Germany

Arran Turnbull United Kingdom

Jiliang Shen China

Ming Jin China

Jin-Woo Kim South Korea

Shane O’Grady Ireland

Özlem Yersal

611 ×1.5

MB

365 ×0.9

ONCOL

222 ×0.7

CR

125 ×0.8

PRM

40 ×0.4

GENET

Citations per year, relative to Özlem Yersal Özlem Yersal (= 1×) peers Shane O’Grady

Countries citing papers authored by Özlem Yersal

Since Specialization

Citations

This map shows the geographic impact of Özlem Yersal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özlem Yersal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özlem Yersal more than expected).

Fields of papers citing papers by Özlem Yersal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Özlem Yersal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özlem Yersal. The network helps show where Özlem Yersal may publish in the future.

Co-authorship network of co-authors of Özlem Yersal

This figure shows the co-authorship network connecting the top 25 collaborators of Özlem Yersal. A scholar is included among the top collaborators of Özlem Yersal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özlem Yersal. Özlem Yersal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Yersal, Özlem, et al.. (2023). Prognostic role of metabolic 18F-FDG PET/CT parameters and hematological prognostic indicators in patients with colorectal cancer. Indian Journal of Cancer. 60(2). 224–229. 2 indexed citations

2.

Yersal, Özlem, et al.. (2022). Prognostic Significance of Fibrinogen-to-Albumin Ratio in Small Cell Lung Cancer. Acta Oncologica Turcica. 55(2). 147–158. 1 indexed citations

3.

Oktay, Esin, et al.. (2022). The Prognostic Importance of Glucose-to-Lymphocyte Ratio and Uric Acid in Metastatic Breast Cancer Patients Treated with Cdk 4/6 Inhibitors. Future Oncology. 18(27). 3043–3053. 7 indexed citations

4.

Yersal, Özlem, et al.. (2022). Prognostic significance of novel inflammatory markers in extensive-stage small-cell lung cancer. Journal of Cancer Research and Therapeutics. 18(3). 691–696. 9 indexed citations

5.

Yersal, Özlem, et al.. (2018). Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens. Cardiology Research and Practice. 2018. 1–6. 22 indexed citations

6.

Yersal, Özlem. (2017). Clinical outcome of patients with glioblastoma multiforme: Single center experience. SHILAP Revista de lepidopterología. 3(3). 123–126. 8 indexed citations

7.

Yersal, Özlem, et al.. (2017). Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios are Not Different among Breast Cancer Subtypes. PubMed. 18(8). 2227–2231. 18 indexed citations

8.

Yersal, Özlem, Erdoğan Malatyalı, Hatice Ertabaklar, et al.. (2016). Blastocystis subtypes in cancer patients: Analysis of possible risk factors and clinical characteristics. Parasitology International. 65(6). 792–796. 38 indexed citations

9.

Tanrıverdi, Özgür, Suna Çokmert, Esin Oktay, et al.. (2016). Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer. The Clinical Respiratory Journal. 12(3). 922–929. 40 indexed citations

10.

Yersal, Özlem. (2014). Biological subtypes of breast cancer: Prognostic and therapeutic implications. World Journal of Clinical Oncology. 5(3). 412–412. 784 indexed citations breakdown →

11.

Özmen, Mustafa, et al.. (2014). Prevalence of the metabolic syndrome in rheumatoid arthritis. European Journal of Rheumatology. 1(1). 1–4. 15 indexed citations

12.

Oktay, Esin, et al.. (2013). Nearly Complete Response of Brain Metastases from HER2 Overexpressing Breast Cancer with Lapatinib and Capecitabine after Whole Brain Irradiation. SHILAP Revista de lepidopterología. 2013. 1–4. 3 indexed citations

13.

Kılçıksız, Sevil, Ayşe Nur Demiral, Mustafa Pehlıvan, et al.. (2008). Clinical and prognostic features of plasmacytomas: A multicenter study of Turkish Oncology Group‐Sarcoma Working Party. American Journal of Hematology. 83(9). 702–707. 43 indexed citations

14.

Somali, Işıl, Özlem Yersal, & Sevil Kılçıksız. (2007). Infratemporal fossa and maxillary sinus metastases from colorectal cancer: a case report.. PubMed. 11(3). 363–5. 3 indexed citations

15.

Yersal, Özlem, et al.. (2005). Autoimmune Polyglandular Syndrome Type II: A Case Report. TURKISH JOURNAL OF MEDICAL SCIENCES. 35(6). 417–419. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact